Comprehensive Exploration of the Therapeutic Potential and Strategies of Omipalisib in Aml: Focus on Nras-Mutated Myeloid Leukemia( II )=完整探索omipalisib在AML中的治療潛力和策略：專注在NRAS突變的髓系白血病( II )

Project title

完整探索omipalisib在AML中的治療潛力和策略：專注在NRAS突變的髓系白血病( II )

Internal ID

NSTC112-2320-B002-008

Principal Investigator

Start Date

August 1, 2023

End Date

July 31, 2024

Organizations

Clinical Laboratory Sciences and Medical Biotechnology

Partner Organizations

National Science and Technology Council

Project Web Site

https://www.grb.gov.tw/search/planDetail?id=15574670